Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicaid Cost-Containment Strategies May Include PDL For Antipsychotics

Executive Summary

Implementing preferred drug lists for mental health drugs may be one cost-containment strategy used by states as they seek to blunt the shift of "dual eligibles" to Medicare

You may also be interested in...



Governors Plan Medicare Rx Education On “Consequences” Of Opting Out

The National Governors Association will work with HHS to educate seniors on the "consequences" of opting out of Medicare drug coverage, NGA Health & Human Services Committee Director Matthew Salo said

Governors Plan Medicare Rx Education On “Consequences” Of Opting Out

The National Governors Association will work with HHS to educate seniors on the "consequences" of opting out of Medicare drug coverage, NGA Health & Human Services Committee Director Matthew Salo said

Medicaid Directors May Seek Clarification On Rebates In Medicare Rx

The National Association of State Medicaid Directors is hoping for clarification that Medicaid rebates will be factored into "clawback" payments made by states for coverage of dual eligibles under the new Medicare drug benefit

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043676

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel